Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.

Suppr

超能文献

作者信息

Kline I, Gang M, Woodman R J, Cysyk R L, Venditti J M

出版信息

Cancer Chemother Rep. 1973 Sep-Oct;57(3):299-304.

PMID:4751256

Abstract

摘要

相似文献

Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.

Cancer Chemother Rep. 1973 Sep-Oct;57(3):299-304.

Potentially useful combinations of chemotherapy detected in mouse tumor systems.

Cancer Chemother Rep 2. 1974 Mar;4(1):33-43.

Synthesis and metabolic behavior of the suggested active species of isophosphamide having cytostatic activity.

J Med Chem. 1974 Nov;17(11):1237-9. doi: 10.1021/jm00257a024.

Phosphorohydrazines of 4-oxo-4H-1-benzopyran and 1-benzopyran-2,4-dione exhibit antitumor activity against L1210 leukemia.

Pharmazie. 2004 Sep;59(9):731-2.

Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).

Cancer Chemother Rep. 1973 Sep-Oct;57(3):291-8.

Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 1. Communication: relationship between chemical structure and pharmacological action.

Arzneimittelforschung. 1974 Aug;24(8):1139-49.

Effect of reserpine (NSC-59272)-induced hypothermia on lifespan in mouse L1210 leukemia.

Cancer Chemother Rep. 1974 May-Jun;58(3):317-24.

Clinical pharmacology of isophosphamide.

Clin Pharmacol Ther. 1974 Jul;16(1):77-86. doi: 10.1002/cpt1974161part177.

Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.

Cancer Chemother Rep. 1972 Aug;56(4):473-81.

Biologic activity of two derivatives and six possible metabolites of cyclophosphamide (NSC-26271).

Cancer Treat Rep. 1976 Apr;60(4):373-9.

引用本文的文献

Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells.

Am J Cancer Res. 2016 Jan 15;6(2):350-69. eCollection 2016.

Antimutagens. Data and problems.

Humangenetik. 1974;24(1):1-32. doi: 10.1007/BF00281107.

Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide.

J Cancer Res Clin Oncol. 1987;113(2):160-5. doi: 10.1007/BF00391439.

Direct search methods in the optimisation of cancer chemotherapy regimens.

Br J Cancer. 1990 Jan;61(1):101-9. doi: 10.1038/bjc.1990.22.

Cyclophosphamide-induced cystitis of the urinary bladder of rats and its treatment.

Proc R Soc Med. 1975 Mar;68(3):169-70. doi: 10.1177/003591577506800309.

Comparative studies on the specificity of anticlastogenic action in human lymphocytes in culture.

Hum Genet. 1976 Apr 15;32(1):49-64. doi: 10.1007/BF00569976.

[On the binding of cyclophosphamide and cyclophosphamide-metabolites to serum-albumin (author's transl)].

Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1978 May 31;91(2):127-42. doi: 10.1007/BF00284020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验